RenalPro for CSA-AKI
Prevention of Acute Kidney Injury post-cardiac surgery
Approved (Breakthrough Device)Active
Key Facts
Indication
Prevention of Acute Kidney Injury post-cardiac surgery
Phase
Approved (Breakthrough Device)
Status
Active
Company
About RenalGuard Solutions
RenalGuard Solutions has developed RenalPro, an automated fluid management system designed to prevent Acute Kidney Injury (AKI). The technology, which has received FDA Breakthrough Device designation, demonstrated a 52% reduction in AKI following cardiac surgery in a randomized controlled trial. The company is positioned to address a major hospital-acquired harm, with CMS set to mandate AKI reporting starting in 2025, creating a significant market driver for preventative solutions.
View full company profile